Robert Fulton

Title: Robert Fulton and Genomic Testing for Multiple Myeloma.

Introduction

Robert Fulton is an inventor associated with Worden, Illinois, and Washington University. His patent work concerns genomic analysis of multiple myeloma, a cancer in which identifying tumor mutations can help inform treatment planning.

Latest Patents

The supplied information lists one patent for Fulton: “Automated Exposition of Known and Novel Multiple Myeloma Genomic Variants Using a Single Sequencing Platform.” The invention describes a sequencing capture array and targeted next-generation sequencing methods for identifying single-nucleotide variants, copy-number variants, and translocations in multiple myeloma tumor cells. The array represents fewer than 500 genes implicated in the disease and can support analysis of tumor mutations to help develop personalized treatment plans. The disclosed analytical methods describe sequencing depths of up to 500×, as low as 100×, and an optimal depth of about 300×. Fulton’s reported patent count is 1 patent.

Career Highlights

The available details connect Fulton’s invention to Washington University and to research focused on applying genomic sequencing to cancer analysis. The patent describes an approach intended to identify both known and novel genetic variants using a single sequencing platform.

Collaborations

Fulton’s listed coworkers include Brian R. White and Irena Lanc. The supplied information does not specify their individual roles in the patent or related research.

Conclusion

Robert Fulton’s reported patent centers on targeted genomic sequencing for multiple myeloma, with the goal of characterizing tumor variants and supporting personalized treatment planning.